ACR Backs FDA Rule Change on Interchangeable Biosimilars The ACR submitted comments to the FDA supporting their proposal to update the approval process for biosimilars’ interchangeability status. https://t.co/YD11qZJxIr https://t.co/tVij0ebwz4